New Enterprise Associates

FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Founded in 2010, Everside Health provides direct primary care services, offering convenient on-site, near-site, and virtual care options for its members. The company's data-driven approach aligns incentives to benefit patients, physicians, and benefit providers while reducing the total cost of care.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

Eargo, Inc. is a consumer-focused medical device company specializing in the design and sale of hearing aids for individuals with hearing loss in the United States. Founded in 2010 and headquartered in San Jose, California, Eargo offers innovative, rechargeable hearing aids that can be controlled via smartphone, enhancing user convenience. The company provides online hearing screenings and virtual support, eliminating the need for in-person consultations. By adopting a direct-to-consumer model, Eargo aims to make hearing aids more accessible and reduce the social stigma often associated with them. Its user-centric approach addresses the common challenges of traditional hearing aid adoption, including cost and accessibility, thereby improving the quality of life for those with hearing difficulties.

Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Cardionomic is a medical device company developing a catheter-based neuromodulation therapy for acute decompensated heart failure. The device delivers targeted electrical stimulation to cardiac nerves via placement in the right pulmonary artery through the internal jugular vein and modulates autonomic signals to improve ventricular contractility without increasing heart rate. The therapy aims to increase cardiac output, renal blood flow, urine production, and pharmacological tolerance while reducing deleterious hormonal signaling associated with heart failure. It addresses the root cause of ADHF by non-systemically enhancing contractility to improve in-hospital outcomes. The company was founded in 2007 and is based in New Brighton, Minnesota.

ChromaCode Inc., established in 2012 and based in Carlsbad, California, specializes in molecular diagnostics. The company develops innovative testing solutions for infectious diseases, cancer, and non-invasive prenatal testing (NIPT) using technology licensed from Caltech. ChromaCode's core products are software, reagents, and assays that enhance the multiplexing capabilities of quantitative PCR (qPCR) instruments by fivefold. Additionally, they offer molecular assays and software for various applications such as personalized medicine and pharmaceutical research. One of their notable products is the HDPCR Tick-Borne Pathogen Panel, a multiplex PCR test detecting common tick-borne pathogens in a single assay. ChromaCode's technology focuses on improving signal processing from life science instrumentation, enabling cost-effective testing of multiple targets simultaneously while integrating into existing laboratory workflows.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

Eargo, Inc. is a consumer-focused medical device company specializing in the design and sale of hearing aids for individuals with hearing loss in the United States. Founded in 2010 and headquartered in San Jose, California, Eargo offers innovative, rechargeable hearing aids that can be controlled via smartphone, enhancing user convenience. The company provides online hearing screenings and virtual support, eliminating the need for in-person consultations. By adopting a direct-to-consumer model, Eargo aims to make hearing aids more accessible and reduce the social stigma often associated with them. Its user-centric approach addresses the common challenges of traditional hearing aid adoption, including cost and accessibility, thereby improving the quality of life for those with hearing difficulties.

FabFitFun is a subscription-based retailer offering curated boxes of health, beauty, and lifestyle products. Every three months, members receive a box filled with full-sized products across categories such as beauty, fashion, wellness, fitness, home, and technology. Additionally, FabFitFun provides streaming video services for on-demand wellness videos and daily lifestyle content, fostering an online community for women to lead healthier lives.

GOQii Inc. is a digital health and wellness company that provides innovative solutions aimed at helping individuals adopt healthier lifestyles. Founded in 2013 and headquartered in Menlo Park, California, with additional offices in Mumbai and Shenzhen, GOQii offers activity tracker wearables and a comprehensive application that monitors various health metrics, including sleep patterns, physical activity, and calories burned. The platform connects users with a diverse range of professional health and fitness coaches, such as nutritionists and personal trainers, who provide personalized guidance through private chats and video calls based on individual health data. Additionally, the app facilitates medical consultations, diagnostic test bookings, and storage of health records in the cloud. GOQii's mission is to empower millions globally to achieve their health goals through a blend of advanced technology and expert support.

Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Founded in 2010, Everside Health provides direct primary care services, offering convenient on-site, near-site, and virtual care options for its members. The company's data-driven approach aligns incentives to benefit patients, physicians, and benefit providers while reducing the total cost of care.

MORE Health, Inc. is a healthcare technology company that has developed a cloud-based physician collaboration platform to facilitate joint diagnosis and treatment planning between attending doctors and specialists. Founded in 2013 and based in Foster City, California, the platform integrates a clinical database containing medical histories, hospital records, lab results, and medical images, along with secure communication tools for real-time discussions. MORE Health offers a variety of services, including a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and a Secure Medical Record service for traveling employees. Initially launched as a concierge service for private clients, it now serves U.S. companies as a supplemental health benefit, providing employees access to top-tier medical expertise during serious health issues. With strategic alliances with prominent medical institutions, MORE Health aims to become a virtual global hospital for serious illnesses, ensuring patients receive the highest quality of diagnosis and treatment when needed.

Founded in 2010, Everside Health provides direct primary care services, offering convenient on-site, near-site, and virtual care options for its members. The company's data-driven approach aligns incentives to benefit patients, physicians, and benefit providers while reducing the total cost of care.

Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

MORE Health, Inc. is a healthcare technology company that has developed a cloud-based physician collaboration platform to facilitate joint diagnosis and treatment planning between attending doctors and specialists. Founded in 2013 and based in Foster City, California, the platform integrates a clinical database containing medical histories, hospital records, lab results, and medical images, along with secure communication tools for real-time discussions. MORE Health offers a variety of services, including a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and a Secure Medical Record service for traveling employees. Initially launched as a concierge service for private clients, it now serves U.S. companies as a supplemental health benefit, providing employees access to top-tier medical expertise during serious health issues. With strategic alliances with prominent medical institutions, MORE Health aims to become a virtual global hospital for serious illnesses, ensuring patients receive the highest quality of diagnosis and treatment when needed.

Radiology Partners is a healthcare service company that provides radiology services through a network of onsite centers across multiple states. It delivers diagnostic and interventional radiology to hospitals, health systems, radiology practices, and other facilities, with investments and support designed to help clients grow their practices while preserving autonomy. The company focuses on transforming radiology for radiologists, practices, patients, and families by offering comprehensive imaging services and collaborative partnerships that improve efficiency and care. Radiology Partners is headquartered in Manhattan Beach, California.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Metavention, Inc., founded in 2012 and based in Dover, Delaware, specializes in developing innovative treatments aimed at permanently disrupting the overactive nerves that contribute to high blood pressure and various metabolic diseases. The company has created a renal denervation procedure that employs radio frequency energy to target and modulate overactive sympathetic nerves. This trans-catheter device not only addresses issues related to high blood pressure but also focuses on conditions such as Type 2 diabetes by employing standard interventional vascular techniques. By providing physicians with advanced tools for diagnosis and treatment, Metavention aims to enhance patient outcomes for those suffering from metabolic disorders linked to sympathetic nervous system activity.

Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

Eargo, Inc. is a consumer-focused medical device company specializing in the design and sale of hearing aids for individuals with hearing loss in the United States. Founded in 2010 and headquartered in San Jose, California, Eargo offers innovative, rechargeable hearing aids that can be controlled via smartphone, enhancing user convenience. The company provides online hearing screenings and virtual support, eliminating the need for in-person consultations. By adopting a direct-to-consumer model, Eargo aims to make hearing aids more accessible and reduce the social stigma often associated with them. Its user-centric approach addresses the common challenges of traditional hearing aid adoption, including cost and accessibility, thereby improving the quality of life for those with hearing difficulties.

Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Radiology Partners is a healthcare service company that provides radiology services through a network of onsite centers across multiple states. It delivers diagnostic and interventional radiology to hospitals, health systems, radiology practices, and other facilities, with investments and support designed to help clients grow their practices while preserving autonomy. The company focuses on transforming radiology for radiologists, practices, patients, and families by offering comprehensive imaging services and collaborative partnerships that improve efficiency and care. Radiology Partners is headquartered in Manhattan Beach, California.

EPIX Therapeutics, Inc. is a medical device company focused on developing innovative temperature-sensing irrigated radiofrequency ablation catheters for treating atrial fibrillation and other cardiac arrhythmias. The company utilizes its proprietary TempaSure technology, which employs microwave radiometry to provide real-time assessment of temperature within the heart, allowing physicians to accurately control lesion formation and enhance clinical outcomes. Founded in 2007 and headquartered in Santa Clara, California, EPIX Therapeutics was previously known as Advanced Cardiac Therapeutics, Inc. and rebranded in August 2018. The company has established strategic partnerships with industry leaders, including Abbott Laboratories and Hansen Medical Inc., to further advance its catheter-based systems aimed at improving the management of irregular heart rhythms. EPIX Therapeutics operates as a subsidiary of Medtronic plc.

ChromaCode Inc., established in 2012 and based in Carlsbad, California, specializes in molecular diagnostics. The company develops innovative testing solutions for infectious diseases, cancer, and non-invasive prenatal testing (NIPT) using technology licensed from Caltech. ChromaCode's core products are software, reagents, and assays that enhance the multiplexing capabilities of quantitative PCR (qPCR) instruments by fivefold. Additionally, they offer molecular assays and software for various applications such as personalized medicine and pharmaceutical research. One of their notable products is the HDPCR Tick-Borne Pathogen Panel, a multiplex PCR test detecting common tick-borne pathogens in a single assay. ChromaCode's technology focuses on improving signal processing from life science instrumentation, enabling cost-effective testing of multiple targets simultaneously while integrating into existing laboratory workflows.

Trillium Therapeutics Inc. is a clinical-stage immuno-oncology company based in Mississauga, Canada, that specializes in developing therapies for cancer treatment. The company focuses on harnessing the immune system to combat malignancies through innovative protein therapeutics. Its lead program, TTI-621, is a SIRPaFc fusion protein currently undergoing Phase I clinical trials for advanced relapsed or refractory hematologic malignancies, solid tumors, and mycosis fungoides. Additionally, Trillium is advancing TTI-622, another SIRPaFc protein in Phase I trials, while also exploring TTI-10001, a small molecule stimulator of interferon genes agonist in the discovery phase. Originally founded in 2004, the company has undergone several name changes, reflecting its evolving focus within the biopharmaceutical sector.

VytronUS, Inc. is a manufacturer of cardiac medical devices, specializing in solutions for treating cardiac arrhythmia. Founded in 2006 and based in Sunnyvale, California, the company develops innovative technologies that leverage ultrasound energy for both imaging and therapeutic purposes. Its devices facilitate precise, non-contact energy delivery and create high-resolution maps of cardiac anatomy, empowering physicians to address complex arrhythmias with enhanced visualization and precision. VytronUS's focus on automation and flexibility in its device offerings positions it as a key player in the cardiac medical device market.

FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.

Eargo, Inc. is a consumer-focused medical device company specializing in the design and sale of hearing aids for individuals with hearing loss in the United States. Founded in 2010 and headquartered in San Jose, California, Eargo offers innovative, rechargeable hearing aids that can be controlled via smartphone, enhancing user convenience. The company provides online hearing screenings and virtual support, eliminating the need for in-person consultations. By adopting a direct-to-consumer model, Eargo aims to make hearing aids more accessible and reduce the social stigma often associated with them. Its user-centric approach addresses the common challenges of traditional hearing aid adoption, including cost and accessibility, thereby improving the quality of life for those with hearing difficulties.

GOQii Inc. is a digital health and wellness company that provides innovative solutions aimed at helping individuals adopt healthier lifestyles. Founded in 2013 and headquartered in Menlo Park, California, with additional offices in Mumbai and Shenzhen, GOQii offers activity tracker wearables and a comprehensive application that monitors various health metrics, including sleep patterns, physical activity, and calories burned. The platform connects users with a diverse range of professional health and fitness coaches, such as nutritionists and personal trainers, who provide personalized guidance through private chats and video calls based on individual health data. Additionally, the app facilitates medical consultations, diagnostic test bookings, and storage of health records in the cloud. GOQii's mission is to empower millions globally to achieve their health goals through a blend of advanced technology and expert support.

Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

Cardionomic is a medical device company developing a catheter-based neuromodulation therapy for acute decompensated heart failure. The device delivers targeted electrical stimulation to cardiac nerves via placement in the right pulmonary artery through the internal jugular vein and modulates autonomic signals to improve ventricular contractility without increasing heart rate. The therapy aims to increase cardiac output, renal blood flow, urine production, and pharmacological tolerance while reducing deleterious hormonal signaling associated with heart failure. It addresses the root cause of ADHF by non-systemically enhancing contractility to improve in-hospital outcomes. The company was founded in 2007 and is based in New Brighton, Minnesota.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

FabFitFun is a subscription-based retailer offering curated boxes of health, beauty, and lifestyle products. Every three months, members receive a box filled with full-sized products across categories such as beauty, fashion, wellness, fitness, home, and technology. Additionally, FabFitFun provides streaming video services for on-demand wellness videos and daily lifestyle content, fostering an online community for women to lead healthier lives.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Median Technologies develops medical imaging software and services for oncology clinical trials and cancer care. It offers iBiopsy, an AI-powered imaging biomarker phenotyping platform that supports translational research and biomarker identification, and iSee, an image analysis and management solution for clinical trials. The company standardizes and automates the interpretation of medical images to optimize cancer diagnosis and the assessment of treatment response, and provides imaging contract research services such as study startup, image and clinical data management, scientific consulting, independent reviews, image data processing, site support, and study close-out. Median Technologies serves drug development and patient care markets with international reach and has partnerships with industry players to expand imaging capabilities. It was founded in 2002 and is headquartered in Valbonne, France.

MORE Health, Inc. is a healthcare technology company that has developed a cloud-based physician collaboration platform to facilitate joint diagnosis and treatment planning between attending doctors and specialists. Founded in 2013 and based in Foster City, California, the platform integrates a clinical database containing medical histories, hospital records, lab results, and medical images, along with secure communication tools for real-time discussions. MORE Health offers a variety of services, including a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and a Secure Medical Record service for traveling employees. Initially launched as a concierge service for private clients, it now serves U.S. companies as a supplemental health benefit, providing employees access to top-tier medical expertise during serious health issues. With strategic alliances with prominent medical institutions, MORE Health aims to become a virtual global hospital for serious illnesses, ensuring patients receive the highest quality of diagnosis and treatment when needed.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

U.S. Renal Care operates a nationwide network of outpatient, home, and specialty dialysis centers delivering in-center and at-home hemodialysis and peritoneal dialysis services for end-stage renal disease. The company runs acute dialysis programs in partnership with local hospitals and supports families, caregivers, and physicians in ESRD care. Founded in 2000 and headquartered in Plano, Texas, it develops and operates dialysis centers through collaborations with local nephrologists, serving tens of thousands of patients across multiple states and select territories, including Guam and, according to some sources, Saudi Arabia.

Median Technologies develops medical imaging software and services for oncology clinical trials and cancer care. It offers iBiopsy, an AI-powered imaging biomarker phenotyping platform that supports translational research and biomarker identification, and iSee, an image analysis and management solution for clinical trials. The company standardizes and automates the interpretation of medical images to optimize cancer diagnosis and the assessment of treatment response, and provides imaging contract research services such as study startup, image and clinical data management, scientific consulting, independent reviews, image data processing, site support, and study close-out. Median Technologies serves drug development and patient care markets with international reach and has partnerships with industry players to expand imaging capabilities. It was founded in 2002 and is headquartered in Valbonne, France.

D2L is a global provider of cloud-based learning solutions for higher education, K-12, healthcare, government, and enterprise. It offers Brightspace, a scalable learning platform with integrated analytics and accessibility features, together with a suite of tools for adaptive learning, content management, assessment, ePortfolios, course catalogs, and campus engagement. The company serves hundreds of clients, including Fortune 1000 organizations, and supports more than eight million learners worldwide. Founded in 1999 and headquartered in Kitchener, Canada, D2L operates with offices and teams across North America, Europe, and Australia to deliver accessible, engaging, and personalized learning experiences.

EPIX Therapeutics, Inc. is a medical device company focused on developing innovative temperature-sensing irrigated radiofrequency ablation catheters for treating atrial fibrillation and other cardiac arrhythmias. The company utilizes its proprietary TempaSure technology, which employs microwave radiometry to provide real-time assessment of temperature within the heart, allowing physicians to accurately control lesion formation and enhance clinical outcomes. Founded in 2007 and headquartered in Santa Clara, California, EPIX Therapeutics was previously known as Advanced Cardiac Therapeutics, Inc. and rebranded in August 2018. The company has established strategic partnerships with industry leaders, including Abbott Laboratories and Hansen Medical Inc., to further advance its catheter-based systems aimed at improving the management of irregular heart rhythms. EPIX Therapeutics operates as a subsidiary of Medtronic plc.

FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Topera Medical is a venture-backed medical device company focused on enhancing the diagnosis and treatment of complex cardiac arrhythmias. It has developed an innovative 3D analysis and mapping system that assists electrophysiologists in identifying the electrical sources of these arrhythmias. The Topera System comprises the RhythmView Workstation and the FIRMap diagnostic catheter, which together offer a dynamic representation of the heart's electrical activity. This technology supports the diagnosis and treatment planning for various arrhythmias, including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia, ultimately aiming to improve patient outcomes.

VytronUS, Inc. is a manufacturer of cardiac medical devices, specializing in solutions for treating cardiac arrhythmia. Founded in 2006 and based in Sunnyvale, California, the company develops innovative technologies that leverage ultrasound energy for both imaging and therapeutic purposes. Its devices facilitate precise, non-contact energy delivery and create high-resolution maps of cardiac anatomy, empowering physicians to address complex arrhythmias with enhanced visualization and precision. VytronUS's focus on automation and flexibility in its device offerings positions it as a key player in the cardiac medical device market.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Panacea Medical Technologies Pvt. Ltd. specializes in the development and manufacturing of medical equipment for radiotherapy and radiology. Founded in 1999 and headquartered in Bengaluru, India, the company offers a range of advanced products, including the Integrated IGRT Unit-G-Ray for image-guided radiotherapy, the Bhabhatron-II for 3D conformal treatment, and Imagin, a flat panel radiotherapy simulator for treatment area localization and plan verification. Other notable products include Karknidon, a high dose rate brachytherapy unit, LILAC for mammography and biopsy, and Uniray 2000 for patient positioning. In addition to its product offerings, Panacea provides support and training services to enhance user experience. The company is committed to innovation and is continuously working to develop new technologies in radiation therapy and diagnosis, driven by a team of skilled engineers dedicated to delivering superior medical solutions.

D2L is a global provider of cloud-based learning solutions for higher education, K-12, healthcare, government, and enterprise. It offers Brightspace, a scalable learning platform with integrated analytics and accessibility features, together with a suite of tools for adaptive learning, content management, assessment, ePortfolios, course catalogs, and campus engagement. The company serves hundreds of clients, including Fortune 1000 organizations, and supports more than eight million learners worldwide. Founded in 1999 and headquartered in Kitchener, Canada, D2L operates with offices and teams across North America, Europe, and Australia to deliver accessible, engaging, and personalized learning experiences.

American Pathology Partners, Inc. is a network of pathology laboratories based in Brentwood, Tennessee, that provides a comprehensive array of anatomic pathology and specialized testing services across the United States. Founded in 2008, the company focuses on various subspecialties, including women's health, surgical pathology, dermatopathology, gastrointestinal pathology, urologic pathology, hematopathology, and molecular testing. American Pathology Partners also offers technical and clinical support services such as immunohistochemistry, flow cytometry, and consultative services. Its laboratory facilities are located in Colorado, Florida, and North Carolina, serving a diverse clientele that includes physicians, hospitals, and surgery centers. The company is committed to delivering accurate diagnoses and rapid turnaround times, while also providing business support services designed to enhance operational efficiency for healthcare providers.

Carticept Medical specializes in developing and distributing medical products aimed at improving the lives of individuals with osteoarthritis or cartilage damage. Their primary offering is a cartilage implant product designed to enhance joint function and alleviate symptoms associated with these conditions. Additionally, they distribute Sonosite ultrasound products, which are used for diagnostic imaging purposes within the orthopedic field.

Roka Bioscience specializes in the development of rapid and accurate molecular assays and instrument systems aimed at the food safety industry. The company's latest innovation, the Atlas System, introduces advanced molecular rapid pathogen testing, which enhances laboratory efficiency through automation and user-friendly design. By focusing on innovative testing solutions, Roka Bioscience aims to assist food manufacturers in minimizing risks, safeguarding their brands, and addressing the growing demands for testing in the sector.

Roka Bioscience specializes in the development of rapid and accurate molecular assays and instrument systems aimed at the food safety industry. The company's latest innovation, the Atlas System, introduces advanced molecular rapid pathogen testing, which enhances laboratory efficiency through automation and user-friendly design. By focusing on innovative testing solutions, Roka Bioscience aims to assist food manufacturers in minimizing risks, safeguarding their brands, and addressing the growing demands for testing in the sector.

NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

InterMune is a biotechnology company focused on pulmonology and orphan fibrotic diseases. It develops targeted small-molecule therapies and biomarkers to treat and monitor serious pulmonary and fibrotic conditions. Its leading therapy pirfenidone, marketed in the European Union as Esbriet, is approved for idiopathic pulmonary fibrosis and is in Phase 3 in the United States to support regulatory registration. The company also maintains a research and development pipeline in hepatology.

Predictive Biosciences, Inc. is a molecular diagnostics company focused on developing diagnostic products aimed at enhancing cancer management. Founded in 2006 and headquartered in Lexington, Massachusetts, the company specializes in proteomics and oncology, particularly in the area of tumor biomarkers. Predictive Biosciences offers a range of assays that detect urinary biomarkers, which are indicative of the physiological changes associated with cancer development and progression. Among its key products are the Triage Monitoring Assay, which enables physicians to postpone invasive diagnostic procedures, the Interval Monitoring Assay for cancer surveillance between follow-up appointments, and the Stratification Assay to assist physicians in managing patient care decisions.

Carticept Medical specializes in developing and distributing medical products aimed at improving the lives of individuals with osteoarthritis or cartilage damage. Their primary offering is a cartilage implant product designed to enhance joint function and alleviate symptoms associated with these conditions. Additionally, they distribute Sonosite ultrasound products, which are used for diagnostic imaging purposes within the orthopedic field.

Founded in 2011, Rock Health is a venture capital firm based in San Francisco. It specializes in investing in and supporting startups working at the intersection of healthcare and technology, with a focus on digital health.

Hygeia Medical Company Limited specializes in manufacturing and supplying a wide range of medical disposable products. Its product offerings include various gauze products such as absorbent rolls and sterile sponges, cotton items like absorbent cotton wool and cotton balls, and an array of bandages including elastic and crepe bandages. The company also produces non-woven items, surgical tapes, and essential surgical instruments, encompassing blood transfusion sets, clinical thermometers, and infusion sets. Additionally, it provides personal protective equipment such as gloves, aprons, and face masks. Hygeia Medical Company serves a global market, distributing its products across Europe, the United States, South America, Africa, and the Middle East. Headquartered in Shanghai, China, the company operates branches and production facilities in Shanghai, Hubei, and Jiangsu provinces.

Nova IVF Fertility operates a network of fertility centers across India, providing a comprehensive range of services related to assisted reproductive technology (ART). Established in 2011 and based in Bengaluru, the company offers various treatments including endoscopy, andrology, infertility counseling and assessment, intrauterine insemination (IUI), in vitro fertilization (IVF), and embryo or sperm donation. Additionally, it provides advanced options like preimplantation genetic screening and assisted hatching. Nova IVF Fertility was created through a collaboration with IVI, a prominent leader in reproductive medicine, to enhance the quality of IVF treatments available in India. The organization aims to raise awareness about infertility as a medical condition that requires treatment, addressing the gap in public knowledge regarding fertility issues. By emphasizing standardized and ethical practices, Nova IVF Fertility seeks to meet the growing demand for infertility services in a country where many couples still remain unaware of their options.

VytronUS, Inc. is a manufacturer of cardiac medical devices, specializing in solutions for treating cardiac arrhythmia. Founded in 2006 and based in Sunnyvale, California, the company develops innovative technologies that leverage ultrasound energy for both imaging and therapeutic purposes. Its devices facilitate precise, non-contact energy delivery and create high-resolution maps of cardiac anatomy, empowering physicians to address complex arrhythmias with enhanced visualization and precision. VytronUS's focus on automation and flexibility in its device offerings positions it as a key player in the cardiac medical device market.

Predictive Biosciences, Inc. is a molecular diagnostics company focused on developing diagnostic products aimed at enhancing cancer management. Founded in 2006 and headquartered in Lexington, Massachusetts, the company specializes in proteomics and oncology, particularly in the area of tumor biomarkers. Predictive Biosciences offers a range of assays that detect urinary biomarkers, which are indicative of the physiological changes associated with cancer development and progression. Among its key products are the Triage Monitoring Assay, which enables physicians to postpone invasive diagnostic procedures, the Interval Monitoring Assay for cancer surveillance between follow-up appointments, and the Stratification Assay to assist physicians in managing patient care decisions.

VytronUS, Inc. is a manufacturer of cardiac medical devices, specializing in solutions for treating cardiac arrhythmia. Founded in 2006 and based in Sunnyvale, California, the company develops innovative technologies that leverage ultrasound energy for both imaging and therapeutic purposes. Its devices facilitate precise, non-contact energy delivery and create high-resolution maps of cardiac anatomy, empowering physicians to address complex arrhythmias with enhanced visualization and precision. VytronUS's focus on automation and flexibility in its device offerings positions it as a key player in the cardiac medical device market.

HemoSense manufactures handheld blood coagulation monitoring systems for the management of warfarin medications for patients and healthcare professionals. It offers INRatio System that measures the patient's blood clotting time to ensure that patients with a propensity to form clots are maintained within the therapeutic range with the proper dosage of oral anticoagulant therapy. The company offers its products through distributor partners. HemoSense, Inc. was formerly known as CardioSense, Inc. and changed its name to HemoSense, Inc. in January 1998. It was founded in 1997 and is based in San Jose, California. As of November 6, 2007, HemoSense, Inc. operates as a subsidiary of Alere Inc.

Appriva Medical is engaged in the design and manufacture of medical equipment for preventing cardioembolic stroke in patients with atrial fibrillation.

WebMD is a prominent provider of health information and services aimed at both consumers and healthcare professionals. The company offers a wide range of resources, including online health-focused publications and decision-support applications, that empower users to manage their health actively. WebMD delivers objective healthcare and lifestyle information through various platforms, enabling individuals to access critical data about conditions such as HIV, diabetes, depression, and cancer. It also serves healthcare professionals by providing access to clinical reference sources, the latest treatment options, and opportunities for continuing medical education. Additionally, WebMD collaborates with employers and health plans to offer personalized health information and decision support tools for employees and plan members, fostering informed choices regarding benefits, providers, and treatment options.

Diatide is engaged in the imaging marketplace, engaged in peptide engineering, molecular biology, and radiolabeling chemistry to develop disease-specific diagnostic and therapeutic agents.

Endocardial Solutions, Inc. specializes in the design, development, and manufacturing of minimally invasive diagnostic systems aimed at diagnosing tachycardia, a serious heart rhythm disorder. The company's flagship product, the EnSite System, integrates a proprietary catheter with a clinical workstation to enable electrophysiologists to quickly and effectively map tachycardia within just a few heartbeats. This advanced diagnostic tool enhances the understanding of the heart's electrical activity and supports more informed treatment decisions. Additionally, Endocardial Solutions develops products for diagnostic mapping of complex arrhythmias, contributing to the treatment of conditions such as atrial fibrillation and significantly improving patient care in the field of electrophysiology.

Life Technologies Corporation is a biotechnology tools company formed in November 2008 from the merger of Invitrogen Corporation and Applied Biosystems, Inc. The company operates under these well-known brands, providing a comprehensive range of systems, consumables, and services that facilitate scientific research and development. Invitrogen specializes in reagents and consumables applicable across various platforms, while Applied Biosystems offers integrated solutions in critical areas such as polymerase chain reaction (PCR), genetic sequencing, and mass spectrometry. Life Technologies' diverse product portfolio includes technologies for capillary electrophoresis-based sequencing, sample preparation, cell culture, RNA interference analysis, functional genomics, proteomics, and cell biology, in addition to applications in clinical diagnostics and water testing analysis. Through its offerings, Life Technologies supports researchers in accelerating their scientific endeavors.